Papers
1
Total Citations
4
H-Index
1
About
Dr. D. Sennung is a leading urologic oncologist whose research focuses on the surgical management of recurrent prostate cancer, with a particular emphasis on precision-guided salvage therapies. Their most notable contribution comes from a prospective exploratory trial on PSMA radioguided salvage lymphadenectomy for prostate cancer recurrence after initial surgery. This landmark study, published in 2024, demonstrated the feasibility of using prostate-specific membrane antigen (PSMA) targeting to guide the removal of metastatic lymph nodes, offering a promising, tailored approach for patients with biochemical recurrence. With 4 citations already, this work is rapidly shaping clinical protocols in salvage surgery. Dr. Sennung’s research bridges the gap between advanced molecular imaging and operative oncology, providing critical data on short-term oncologic outcomes. Their work is instrumental in refining treatment algorithms for recurrent prostate cancer, offering patients a more precise, less morbid alternative to systemic therapy.
Research Focus
Key Achievements
Top Papers
- 1